Circle8 Group, Inc. (NASDAQ: CIRC) AI-Powered Stock Analysis
See how Circle8 Group, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
CIRC●NASDAQ
HealthcareMedical - Pharmaceuticals
$0.70
$0.02(3.21%)
U.S. Market opens in 11h 42m
Circle8 Group, Inc. (NASDAQ: CIRC) AI-Powered Stock Analysis
See how Circle8 Group, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerCircle8 Group, Inc. (NASDAQ: CIRC) Stock Overall Grade
Circle8 Group, Inc.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Circle8 Group, Inc.'s overall NASDAQ stock rating.
Forecast
C+Score
51/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
50/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Circle8 Group, Inc. (NASDAQ: CIRC) AI-Powered Stock Analysis
On the NASDAQ, CIRC demonstrates Normal performance with an overall Forecast Score of 51/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(NASDAQ: CIRC) Component Analysis Explained
Understand the key factors behind each Circle8 Group, Inc. (NASDAQ: CIRC) stock grade, including financials, comparisons, and forecasts.